Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 month ...

An Ozempic user has revealed one unexpected side effect that's 'causing issues in their relationship'. While many people are having a lot of success taking GLP-1 drugs such as Ozempic, Mounjaro and ...

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

Experts have shared their thoughts on the impacts that GLP-1 medications such as Ozempic can have on libido as a side effect ...